News | Peripheral Artery Disease (PAD)

Patients with peripheral artery disease (PAD) were significantly less likely to face amputation after surgical intervention if they were on statin medications, according to a newly released report in the Journal for Vascular Surgery.1 Those patients also had fewer deaths over the 88-month review period.

Home August 23, 2019
Home
Technology | Catheters

August 23, 2019 — Cook Medical recently released the second generation of the 2.6 Fr CXI Support Catheter with platinum ...

Home August 23, 2019
Home
Podcast | Structural Heart

John Carroll, M.D., FACC, FSCAI, director of interventional cardiology at the Cardiac and Vascular Center at the ...

Home August 23, 2019
Home
Videos | Chronic Total Occlusion (CTO)

Interview with Kevin Rogers, M.D., director of vascular medicine at the University of Colorado Hospital. He explains ...

Home August 23, 2019
Home
News | Stem Cell Therapies

August 22, 2019 — Renovacor Inc, a preclinical-stage biopharmaceutical company, announced the successful completion of ...

Home August 22, 2019
Home
News | Cardiovascular Surgery

The amount of opioids prescribed for patients after heart and lung surgery has a direct relationship with the risk for opioid dependency and “persistent opioid use” several months after the operation, according to new research. The study is published online in The Annals of Thoracic Surgery.

Home August 22, 2019
Home
News | Heart Valve Technology

Edwards Lifesciences is recalling the Sapien 3 Ultra delivery system after receiving reports of burst balloons during implantation procedures, which have resulted in significant difficulty retrieving the valve into the catheter and withdrawing the system from the patient. The company said this may cause vascular injury, bleeding or surgical intervention.

Home August 22, 2019
Home
News | Stents

Increasing incidence of cardiovascular diseases worldwide is creating growth opportunities for the global cardiovascular stents market, predicts Fortune Business Insights in a new study.

Home August 21, 2019
Home
News | Angiography

Jackson Memorial Hospital in Miami celebrated the opening of two newly renovated cardiac catheterization suites during a ribbon-cutting ceremony on August 19, 2019. The suites feature the new Alphenix Core+ from Canon Medical Systems, which provides diverse imaging without compromising image quality or performance. Jackson Memorial is the first hospital in Florida offering this new technology.

Home August 21, 2019
Home
News | Hypertension

In a study that spanned two and a half decades and looked at data from more than 4,700 participants, Johns Hopkins researchers have added to evidence that abnormal blood pressure in midlife persisting into late life increases the likelihood of developing dementia. Although not designed to show cause and effect, the study suggests that maintaining a healthy blood pressure throughout life may be one way to help decrease one’s risk of losing brain function.

Home August 20, 2019
Home
News | Ventricular Assist Devices (VAD)

Left ventricular assist devices (LVADs) have been shown to help leaky mitral valves that create significant regurgitation, but a new study questions the presumption that all’s well with the mitral valve after a patient receives a LVAD.

Home August 20, 2019
Home
News | Cybersecurity

Healthcare data breaches are currently being reported at a rate of more than one a day, according to a new report from the nonprofit Institute for Healthcare IT (IHIT). And for those who think it can’t happen to them, the odds are not in their favor. Breaches reported between 2009 and 2018 have resulted in the theft or exposure of almost 190 million healthcare records, a number equal to 59 percent of the U.S. population, according to the HIPAA Journal.

Home August 20, 2019
Home
News | Cardiac Diagnostics

People suffering from insomnia may have an increased risk of coronary artery disease, heart failure and stroke, according to new research in the American Heart Association’s journal Circulation.

Home August 19, 2019
Home
Technology | Heart Failure

The U.S. Food and Drug Administration (FDA) approved the Barostim Neo System for the improvement of symptoms in patients with advanced heart failure who are not suited for treatment with other heart failure devices, such as cardiac resynchronization therapy. The FDA gave the device a Breakthrough Device designation because it treats a life-threatening disease, heart failure, and addresses an unmet medical need in patients who fail to get adequate benefits from standard treatments and have no alternative treatment options.

Home August 19, 2019
Home
News | EP Mapping and Imaging Systems

Scientists at Johns Hopkins have successfully created personalized digital replicas of the upper chambers of the heart and used them to guide the precise treatment of patients suffering from persistent irregular heartbeats. These simulations accurately identified where clinicians need to destroy tissue to restore the heart’s normal rhythm.

Home August 19, 2019
Home
Subscribe Now